{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:18:21Z","timestamp":1793171901335,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["16H02643"],"award-info":[{"award-number":["16H02643"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Tuberculosis is associated with increased risk of cancer. However, the impact of tuberculosis on global cancer burden is unknown.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We performed random-effects meta-analyses and meta-regressions of studies reporting the association between tuberculosis and cancer risks by searching PubMed, Web of Science, Embase, Cochrane library, and CINAHL from inception to 1 June 2019. Population attributable fractions (PAFs) of cancer incidence attributable to tuberculosis were calculated using relative risks from our meta-analyses and tuberculosis prevalence data from Global Health Data Exchange by age, sex, and country. The study has been registered with PROSPERO (CRD42016050691).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Fourty nine studies with 52,480 cancer cases met pre-specified inclusion criteria. Tuberculosis was associated with head and neck cancer (RR 2.64[95% CI 2.00\u20133.48]), hepatobiliary cancer (2.43[1.82\u20133.25]), Hodgkin\u2019s lymphoma (2.19[1.62\u20132.97]), lung cancer (1.69[1.46\u20131.95]), gastrointestinal cancer (1.62[1.26\u20132.08]), non-Hodgkin\u2019s lymphoma (1.61[1.34\u20131.94]), pancreatic cancer (1.58[1.28\u20131.96]), leukaemia (1.55[1.25\u20131.93]), kidney and bladder cancer (1.54[1.21\u20131.97]), and ovarian cancer (1.43[1.04\u20131.97]). We estimated that 2.33%(1.14\u20133.81) or 381,035(187145\u2013623,404) of global cancer incidences in 2015 were attributable to tuberculosis. The PAFs varied by Socio-demographic Index (SDI)\u2014ranging from 1.28% (0.57\u20132.31%) in the high-SDI countries to 3.51% (1.84\u20135.42%) in the middle-SDI countries. Individually, China and India accounted for 47% of all tuberculosis-related cancer cases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Tuberculosis is associated with increased risk of cancer at ten sites. The burden of tuberculosis attributable cancer skewed towards lower resource countries. Research priorities are to better understand regional disparities and underlying mechanism linking tuberculosis and cancer development.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-06891-5","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T18:03:31Z","timestamp":1589306611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cancer incidence attributable to tuberculosis in 2015: global, regional, and national estimates"],"prefix":"10.1186","volume":"20","author":[{"given":"Chi Yan","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Mizanur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Krull Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"6891_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2017.1747","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524\u201348.","journal-title":"JAMA Oncol"},{"key":"6891_CR2","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609\u201316.","journal-title":"Lancet Glob Health"},{"key":"6891_CR3","volume-title":"Global tuberculosis report 2017","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization; 2017. http:\/\/apps.who.int\/iris\/bitstream\/10665\/259366\/1\/9789241565516-eng.pdf. Accessed 15 Nov 2017."},{"key":"6891_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1470-2045(11)70105-X","volume":"12","author":"S Vento","year":"2011","unstructured":"Vento S, Lanzafame M. Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol. 2011;12:520\u20132.","journal-title":"Lancet Oncol"},{"key":"6891_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1473-3099(13)70015-X","volume":"13","author":"BJ Marais","year":"2013","unstructured":"Marais BJ, Loennroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013;13:436\u201348.","journal-title":"Lancet Infect Dis"},{"key":"6891_CR6","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/onc.2009.32","volume":"28","author":"A Nalbandian","year":"2009","unstructured":"Nalbandian A, Yan BS, Pichugin A, Bronson RT, Kramnik I. Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control. Oncogene. 2009;28:1928\u201338.","journal-title":"Oncogene."},{"key":"6891_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/444545","volume":"192","author":"K Dheda","year":"2005","unstructured":"Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, et al. Lung remodeling in pulmonary tuberculosis. J Infect Dis. 2005;192:1201\u20139.","journal-title":"J Infect Dis"},{"key":"6891_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2015.11.007","volume":"300","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Tripathi D, Kulkarni S, Rajan MG. Mycobacterium tuberculosis H37Rv infected THP-1 cells induce epithelial mesenchymal transition (EMT) in lung adenocarcinoma epithelial cell line (A549). Cell Immunol. 2016;300:33\u201340.","journal-title":"Cell Immunol"},{"key":"6891_CR9","doi-asserted-by":"publisher","first-page":"e17479","DOI":"10.1371\/journal.pone.0017479","volume":"6","author":"DR Brenner","year":"2011","unstructured":"Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 2011;6:e17479.","journal-title":"PLoS One"},{"key":"6891_CR10","unstructured":"Wong JY, Zhang H, Hsiung CA, Shiraishi K, Yu K, Matsuo K, et al. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women. Genomics. 2019;Forthcoming."},{"key":"6891_CR11","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA group. Preferred reporting items for systematic reviews and meta-analyses protocols: the PRISMA statement. PLos Med. 2009;6:e1000097.","journal-title":"PLos Med"},{"key":"6891_CR12","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388:e19\u201323.","journal-title":"Lancet"},{"key":"6891_CR13","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. 2017. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 15 Sept 2018."},{"key":"6891_CR14","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Kai FY. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690\u20131.","journal-title":"JAMA"},{"key":"6891_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"6891_CR16","first-page":"531","volume":"9","author":"ML Levin","year":"1953","unstructured":"Levin ML. The occurrence of lung cancer in man. Acta-Unio Int Contra Cancrum. 1953;9:531\u201341.","journal-title":"Acta-Unio Int Contra Cancrum"},{"key":"6891_CR17","volume-title":"Global Burden of Disease Study 2016 (GBD 2016) Results","author":"Global Burden of Disease Collaborative Network","year":"2017","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2017. http:\/\/ghdx.healthdata.org\/gbd-2016. Accessed 25 May 2018."},{"key":"6891_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/oxfordjournals.aje.a009523","volume":"147","author":"LE Daly","year":"1998","unstructured":"Daly LE. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol. 1998;147:783\u201390.","journal-title":"Am J Epidemiol"},{"key":"6891_CR19","volume-title":"IARC working group report","author":"International Agency for Research on Cancer","year":"2007","unstructured":"International Agency for Research on Cancer. Attributable Causes of Cancer in France in the Year 2000. In: IARC working group report, vol. 3. Lyon, France: IARC Scientific Publications; 2007. http:\/\/wwwiarcfr\/en\/publications\/pdfs-online\/wrk\/wrk3\/indexphp 18 May 2018."},{"key":"6891_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ijc.27477","volume":"131","author":"J Sisti","year":"2012","unstructured":"Sisti J, Boffetta P. What proportion of lung cancer in never-smokers can be attributed to known risk factors? Int J Cancer. 2012;131:265\u201375.","journal-title":"Int J Cancer"},{"key":"6891_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759\u201371.","journal-title":"Nat Rev Cancer"},{"key":"6891_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc3169","volume":"12","author":"F Martin-Belmonte","year":"2011","unstructured":"Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer. 2011;12:23\u201338.","journal-title":"Nat Rev Cancer"},{"key":"6891_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/cid\/cix209","volume":"64","author":"MP Cheng","year":"2017","unstructured":"Cheng MP, Chakra CN, Yansouni CP, Cnossen S, Shrier I, Menzies D, et al. Risk of active tuberculosis in patients with cancer: a systematic review and meta-analysis. Clin Infect Dis. 2017;64:635\u201344.","journal-title":"Clin Infect Dis"},{"key":"6891_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/ije\/30.1.118","volume":"30","author":"AV Brenner","year":"2001","unstructured":"Brenner AV, Wang Z, Kleinerman RA, Wang L, Zhang S, Metayer C, et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol. 2001;30:118\u201324.","journal-title":"Int J Epidemiol"},{"key":"6891_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.5588\/ijtld.14.0161","volume":"18","author":"DF Simonsen","year":"2014","unstructured":"Simonsen DF, Farkas DK, S\u00f8gaard M, Horsburgh CR, S\u00f8rensen HT, Thomsen RW. Tuberculosis and risk of cancer: a Danish nationwide cohort study. Int J Tuberc Lung Dis. 2014;18:1211\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6891_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bjc.1987.233","volume":"56","author":"W Zheng","year":"1987","unstructured":"Zheng W, Blot WJ, Liao ML, Wang ZX, Levin LI, Zhao JJ, et al. Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer. 1987;56:501\u20134.","journal-title":"Br J Cancer"},{"key":"6891_CR27","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1016\/S2214-109X(16)30199-1","volume":"4","author":"RM Houben","year":"2016","unstructured":"Houben RM, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health. 2016;4:e806\u201315.","journal-title":"Lancet Glob Health"},{"key":"6891_CR28","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161\u201370.","journal-title":"N Engl J Med"},{"key":"6891_CR29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(17)30790-0","volume":"389","author":"M Pai","year":"2017","unstructured":"Pai M, Correa N, Mistry N, Jha P. Reducing global tuberculosis deaths\u2014time for India to step up. Lancet. 2017;389:1174\u20136.","journal-title":"Lancet"},{"key":"6891_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/bmj.316.7125.140","volume":"316","author":"M Egger","year":"1998","unstructured":"Egger M, Schneider M, Smith GD. Spurious precision? Meta-analysis of observational studies. BMJ. 1998;316:140\u20134.","journal-title":"BMJ"},{"key":"6891_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"6891_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1473-3099(17)30703-X","volume":"18","author":"GT Collaborators","year":"2018","unstructured":"Collaborators GT. The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis. 2018;18:261\u201384.","journal-title":"Lancet Infect Dis"},{"key":"6891_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1470-2045(08)70154-2","volume":"9","author":"ND Freedman","year":"2008","unstructured":"Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008;9:649\u201356.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-06891-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:30:28Z","timestamp":1620775828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-06891-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6891"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06891-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}